Psyence BioMed (Nasdaq: PBM) announced that its strategic partner, PsyLabs, has successfully produced a GMP-aligned Ibogaine Total Alkaloid extract meeting food-grade consumption safety standards. This achievement follows PBM’s strategic equity investments in PsyLabs during 2024 and 2025.
The breakthrough represents a significant milestone in producing high-quality psychedelic APIs, with PsyLabs’ extract passing third-party laboratory verification. ...
Creekmore described Ibogaine as a psychoactive substance derived from the Iboga plant found in Africa. There is evidence to support the …
The Drug Enforcement Administration classifies ibogaine, a psychedelic drug derived from an African shrub, as a Schedule I drug with no currently …
The psychoactive treatment is said to be effective in treating PTSD, trauma and addiction.
Lawmakers will hold a hearing in August to determine whether a bill allowing FDA trials of a drug said to be able to cure people who are suffering from addiction, PTSD or trauma should be introduced in the Mississippi Legislature next session.
State Rep. Samuel Creekmore (R), Chairman of the House Public Health and Human Services Committee, plans to hold ...
This story is part of The Trip, a CPR News series on Colorado’s new psychedelic movement. Read more here.
A psychedelic drug that comes from the iboga shrub in Central Africa is among those decriminalized by Colorado voters in 2022 and now it’s being reviewed by the state for treating substance use disorders. Proponents say Ibogaine helps reduce withdrawal symptoms in people addicted to opioids ...